These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12235187)

  • 1. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
    Borradaile NM; de Dreu LE; Barrett PH; Huff MW
    J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
    Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
    Wilcox LJ; Borradaile NM; de Dreu LE; Huff MW
    J Lipid Res; 2001 May; 42(5):725-34. PubMed ID: 11352979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
    Wilcox LJ; Barrett PH; Huff MW
    J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
    Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
    Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-site model for ApoB degradation in HepG2 cells.
    Wu X; Sakata N; Lele KM; Zhou M; Jiang H; Ginsberg HN
    J Biol Chem; 1997 Apr; 272(17):11575-80. PubMed ID: 9111073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells.
    Furukawa S; Sakata N; Ginsberg HN; Dixon JL
    J Biol Chem; 1992 Nov; 267(31):22630-8. PubMed ID: 1429611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
    Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells.
    Avramoglu RK; Cianflone K; Sniderman AD
    J Lipid Res; 1995 Dec; 36(12):2513-28. PubMed ID: 8847478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of ApoB-containing lipoproteins.
    Wu X; Zhou M; Huang LS; Wetterau J; Ginsberg HN
    J Biol Chem; 1996 Apr; 271(17):10277-81. PubMed ID: 8626595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation.
    Kulinski A; Rustaeus S; Vance JE
    J Biol Chem; 2002 Aug; 277(35):31516-25. PubMed ID: 12072432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin.
    Borradaile NM; Carroll KK; Kurowska EM
    Lipids; 1999 Jun; 34(6):591-8. PubMed ID: 10405973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.
    Allister EM; Mulvihill EE; Barrett PH; Edwards JY; Carter LP; Huff MW
    J Lipid Res; 2008 Oct; 49(10):2218-29. PubMed ID: 18587069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein B-containing lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfected COS-7 cells.
    Wang S; McLeod RS; Gordon DA; Yao Z
    J Biol Chem; 1996 Jun; 271(24):14124-33. PubMed ID: 8662886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2).
    Haghpassand M; Wilder D; Moberly JB
    J Lipid Res; 1996 Jul; 37(7):1468-80. PubMed ID: 8827519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.
    Cianflone KM; Yasruel Z; Rodriguez MA; Vas D; Sniderman AD
    J Lipid Res; 1990 Nov; 31(11):2045-55. PubMed ID: 1964953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
    Wilcox LJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells.
    Wu X; Shang A; Jiang H; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3347-55. PubMed ID: 9409332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.
    Sakata N; Wu X; Dixon JL; Ginsberg HN
    J Biol Chem; 1993 Nov; 268(31):22967-70. PubMed ID: 8226809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J; Kazemian P; Kulinski A; Rudy D; Aiton A; Thibert RJ; Adeli K
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1035-47. PubMed ID: 11027587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.